First Trust Advisors LP boosted its position in shares of Clarivate Plc (NYSE:CLVT – Get Rating) by 48.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 761,824 shares of the company’s stock after buying an additional 247,337 shares during the quarter. First Trust Advisors LP’s holdings in Clarivate were worth $7,153,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLVT. CWM LLC raised its holdings in Clarivate by 341.6% in the 3rd quarter. CWM LLC now owns 3,705 shares of the company’s stock worth $35,000 after purchasing an additional 2,866 shares in the last quarter. Wahed Invest LLC purchased a new stake in shares of Clarivate in the 2nd quarter worth about $64,000. Penserra Capital Management LLC grew its position in shares of Clarivate by 50.0% in the 1st quarter. Penserra Capital Management LLC now owns 5,322 shares of the company’s stock worth $89,000 after buying an additional 1,774 shares during the period. Neo Ivy Capital Management purchased a new stake in shares of Clarivate in the 2nd quarter worth about $80,000. Finally, Forsta AP Fonden purchased a new stake in shares of Clarivate in the 2nd quarter worth about $139,000. 87.34% of the stock is currently owned by institutional investors.
Clarivate Stock Performance
Shares of NYSE CLVT opened at $10.00 on Tuesday. The firm’s 50-day moving average price is $10.52 and its 200-day moving average price is $10.08. The company has a quick ratio of 0.89, a current ratio of 0.89 and a debt-to-equity ratio of 0.92. The company has a market cap of $6.74 billion, a PE ratio of -1.61 and a beta of 1.09. Clarivate Plc has a 52-week low of $7.85 and a 52-week high of $17.50.
Wall Street Analysts Forecast Growth
Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines.
- Get a free copy of the StockNews.com research report on Clarivate (CLVT)
- First Republic: First Rate Risk or Time To Buy?
- These Hedge Funds Are Getting Crushed By SVB
- Buy The Dip In The Charles Schwab Corporation
- ZIM Integrated Shipping Services: Up 15% But Don’t Chase It
- FedEx Is A Buy Going Into Earnings
Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVT – Get Rating).
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.